Garden-variety vaccines: Antigens derived from transgenic plants

Expert Review of Vaccines

Volumn 3, Issue 5, 2004, Pages 529-531

  Tacket, Carol O ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

Transgenic plants; Vaccine antigen

Indexed keywords

CAPSID PROTEIN; DNA VACCINE; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI ENTEROTOXIN B; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; PLANT DERIVED VACCINE; PLANT EXTRACT; UNCLASSIFIED DRUG; VACCINE;

ANTIBODY PRODUCTION; ANTIGEN DETECTION; ANTIGEN PURIFICATION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ECONOMIC ASPECT; GENE DELETION; GENE EXPRESSION; GENETICALLY MODIFIED CROP; GENOMICS; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPHARMACOLOGY; LETTUCE; NOROVIRUS; PLANT VIRUS; POTATO; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TECHNOLOGY; TRANSGENIC PLANT; VACCINE PRODUCTION;

ANTIGENS, VIRAL; CLINICAL TRIALS; HUMANS; PLANTS, GENETICALLY MODIFIED; VACCINES, EDIBLE; VIRAL VACCINES;

EID: 7444225276     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.3.5.529     Document Type: Review

References (11)

1. Beutels P. Economic evaluations applied to HB vaccination: general observations. Vaccine 16, S84-S92 (1998).
2. Stein KE, Webber KO. The regulation of biologic products derived from bioengineered plants. Curr. Opin. Biotechnol. 12, 308-311 (2001).
3. Sala F, Manuela RM, Barbante A et al. Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine 21, 803-808 (2003).
4. Streatfield SJ, Jilka JM, Hood EE et al. Plant-based vaccines: unique advantages. Vaccine 19, 2742-2748 (2001).
5. Tacket CO, Mason HS, Losonsky G et al. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Med. 4, 607-609 (1998).
6. Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine, In Press (2004).
7. Tacket CO, Losonsky G, Estes MK et al. Immunogenicity of recombinant norwalk virus capsid protein delivered in transgenic potatoes. J. Infect. Dis. 182, 302-305 (2000).
8. Kapusta J, Modelska A, Figlerowicz M et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13, 1796-1799 (1999).
9. Kapusta J, Modelsak A, Pniewski T et al. Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Adv. Exp. Biol Med. 495, 299-303 (2001).
10. Arntzen CJ, Coghlan A, Johnson B, Peacock J, Rodemeyer M. Nature Rev. Gen. 4, 839-843 (2003).
11. Vermij P. Edible vaccines not ready for main course. Nature Med. 10, 881 (2004).